Investigation of Chronotropic Index, Exercise Capacity in Type 1 Diabetes Mellitus
1 other identifier
observational
54
1 country
1
Brief Summary
To investigate whether diabetes affects lung function and exercise capacity and impairs autonomic nervous system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 20, 2020
CompletedFirst Submitted
Initial submission to the registry
March 25, 2021
CompletedFirst Posted
Study publicly available on registry
March 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedMarch 22, 2022
March 1, 2022
1.5 years
March 25, 2021
March 21, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Exercise Capacity
The maximal exercise capacity of the individuals will be evaluated by the incremental shuttle walk test. This test is a symptom-limited maximal field test that evaluates maximal exercise capacity with progressively increased walking speed.
First Day
Chronotropic index
The chronotropic index will be calculated using the results of the maximal exercise test.
First Day
Secondary Outcomes (12)
Pulmonary function (Forced vital capacity (FVC))
First Day
Pulmonary function (Forced expiratory volume in the first second (FEV1))
First Day
Pulmonary function (FEV1 / FVC)
First Day
Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%))
First Day
Pulmonary function (Peak flow rate (PEF))
First Day
- +7 more secondary outcomes
Study Arms (2)
Type 1 diabetes mellitus
Patients Maximal exercise capacity (Incremental shuttle walk test), respiratory functions (spirometer), respiratory muscle strength (mouth pressure measurement), peripheral muscle strength (dynamometer), respiratory muscle endurance ( incremental threshold loading test), physical activity level (multi sensor activity monitor), quality of life (World Health Organization (WHO) well-being index), fatigue (fatigue severity scale), shortness of breath (Modified Medical Research Council MMRC) will be evaluated.
Healthy Controls
Maximal exercise capacity (Incremental shuttle walk test), respiratory functions (spirometer), respiratory muscle strength (mouth pressure measurement), peripheral muscle strength (dynamometer), respiratory muscle endurance ( incremental threshold loading test), physical activity level (multi sensor activity monitor), quality of life (World Health Organization (WHO) well-being index), fatigue ( fatigue severity scale), shortness of breath (Modified Medical Research Council MMRC) will be evaluated.
Eligibility Criteria
27 patients with Type 1 Diabetes mellitus and 27 healthy individuals will be included.
You may qualify if:
- Individuals aged 18-65 years diagnosed with Type 1 diabetes by basic clinical and laboratory techniques
- Individuals using pump and injection insulin to control type 1 diabetes
- Willing to participate to the study
- Between ages of 18 and 65
You may not qualify if:
- Individuals with body mass index\> 30 kg / m²
- those with lower limb amputation
- those with any heart disease
- Individuals with type 2 diabetes
- Individuals who smoke 10 pack×years
- Anemia
- Individuals with diabetic foot
- Individuals with orthopedic problems
- Individuals with balance problems
- Myocardial infarction or other acute cardiac events within 2 days
- Unstable angina
- Uncontrolled heart rhythm causing symptoms or hemodynamic effects
- Uncontrolled symptomatic heart failure
- Acute pulmonary embolism or pulmonary infarction
- Acute myocarditis or pericarditis
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gazi Universitylead
Study Sites (1)
Gazi University Faculty of Health Sciences Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Unit
Ankara, Çankaya, 06490, Turkey (Türkiye)
Related Publications (5)
Sydo N, Sydo T, Merkely B, Carta KG, Murphy JG, Lopez-Jimenez F, Allison TG. Impaired Heart Rate Response to Exercise in Diabetes and Its Long-term Significance. Mayo Clin Proc. 2016 Feb;91(2):157-65. doi: 10.1016/j.mayocp.2015.10.028. Epub 2016 Jan 5.
PMID: 26769183BACKGROUNDKomatsu WR, Gabbay MA, Castro ML, Saraiva GL, Chacra AR, de Barros Neto TL, Dib SA. Aerobic exercise capacity in normal adolescents and those with type 1 diabetes mellitus. Pediatr Diabetes. 2005 Sep;6(3):145-9. doi: 10.1111/j.1399-543X.2005.00120.x.
PMID: 16109070BACKGROUNDGoldman MD. Lung dysfunction in diabetes. Diabetes Care. 2003 Jun;26(6):1915-8. doi: 10.2337/diacare.26.6.1915. No abstract available.
PMID: 12766133BACKGROUNDFuso L, Pitocco D, Longobardi A, Zaccardi F, Contu C, Pozzuto C, Basso S, Varone F, Ghirlanda G, Antonelli Incalzi R. Reduced respiratory muscle strength and endurance in type 2 diabetes mellitus. Diabetes Metab Res Rev. 2012 May;28(4):370-5. doi: 10.1002/dmrr.2284.
PMID: 22271438BACKGROUNDMiculis CP, De Campos W, da Silva Boguszweski MC. Correlation between glycemic control and physical activity level in adolescents and children with type 1 diabetes. J Phys Act Health. 2015 Feb;12(2):232-7. doi: 10.1123/jpah.2013-0024. Epub 2014 Feb 5.
PMID: 24508755BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Meral BOŞNAK GÜÇLÜ, Prof. Dr.
Gazi Universitiy
- STUDY CHAIR
Ayşenur SARISAKALOĞLU, Pt
Gazi Universitiy
- PRINCIPAL INVESTIGATOR
Meriç COŞKUN, Dr.
Gazi Universitiy
- PRINCIPAL INVESTIGATOR
Füsun BALOŞ TÖRÜNER, Prof.Dr.
Gazi Universitiy
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
March 25, 2021
First Posted
March 29, 2021
Study Start
January 20, 2020
Primary Completion
July 30, 2021
Study Completion
September 30, 2021
Last Updated
March 22, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share